NCT06079541

Phase 1 Clinical Study of JMKX003142 Tablets

Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142 Tablets Administered Randomly, Double-blind, Placebo-controlled Single and Multiple Times in Healthy Adult Subjects, as Well as the Effects of Randomized, Open, and Two Cycle Crossover Foods

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 106 (estimated)
• Sponsor: Jemincare · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of JMKX003142 tablets administered randomly, double-blind, placebo-controlled single and multiple times in healthy adult subjects, as well as the effects of randomized, open, and two cycle crossover foods

Conditions

• Safety and Tolerability

Interventions

Type	Name	Description
DRUG	JMKX003142 will be administered orally	oral once
DRUG	JMKX003142 will be administered orally	oral once
DRUG	JMKX003142 will be administered orally	oral once
DRUG	Placebo in Cohorts 1 to 7	oral once
DRUG	Placebo in 3 Cohorts	oral once

Timeline

• Start date: 2023-07-06
• Primary completion: 2024-07-31
• Completion: 2025-03-30
• First posted: 2023-10-12
• Last updated: 2023-10-17

Locations

1 site across 1 country: China